PMID- 28188026 OWN - NLM STAT- MEDLINE DCOM- 20180321 LR - 20211204 IS - 1879-1476 (Electronic) IS - 0385-8146 (Linking) VI - 44 IP - 4 DP - 2017 Aug TI - Clinical significance of integrin-linked kinase in laryngeal squamous cell carcinoma. PG - 458-463 LID - S0385-8146(16)30364-9 [pii] LID - 10.1016/j.anl.2016.09.002 [doi] AB - OBJECTIVE: To investigate the expression of integrin-linked kinase (ILK) and its relationship with clinicopathological parameters in laryngeal squamous cell carcinoma (LSCC). METHODS: 116 patients who had previously undergone complete resection of tumor for LSCC were studied retrospectively. The level of ILK expression in tumor tissues and adjacent nontumor tissues were determined by immunohistochemistry. RESULTS: Increased expression of ILK was found in 65.5% of cases. The expression of ILK protein was significantly associated with tumor grade (p=0.046), lymph node metastasis (p=0.020), and pTNM stage (p=0.019). Kaplan-Meier survival estimates showed a significant correlation between ILK expression and patient survival rate (log-rank p<0.05). The multivariate survival analysis revealed that N status was statistically significant prognostic factor (p<0.001). Other parameters, such as ILK expression, cannot predict disease prognosis separately. CONCLUSION: Increased expression of integrin-linked kinase is associated with lymph node metastases and patient survival rate in laryngeal squamous cell carcinoma. However, it does not appear to be an independent prognostic predictor in LSCC. CI - Copyright (c) 2016 Elsevier Ireland Ltd. All rights reserved. FAU - Wu, Ping-An AU - Wu PA AD - Department of Otolaryngology, Head and Neck Surgery, The University of Hong Kong-Shenzhen Hospital, Shenzhen 518053, Guangdong, PR China; Department of Otolaryngology, Head and Neck Surgery, The Second Xiangya Hospital, Central South University, Changsha 410011, Hunan, PR China. FAU - Li, Shi-Sheng AU - Li SS AD - Department of Otolaryngology, Head and Neck Surgery, The Second Xiangya Hospital, Central South University, Changsha 410011, Hunan, PR China. FAU - Tang, Qing-Lai AU - Tang QL AD - Department of Otolaryngology, Head and Neck Surgery, The Second Xiangya Hospital, Central South University, Changsha 410011, Hunan, PR China. FAU - Liu, Bing-Bing AU - Liu BB AD - Department of Otolaryngology, Head and Neck Surgery, The Second Xiangya Hospital, Central South University, Changsha 410011, Hunan, PR China. FAU - Yang, Xin-Ming AU - Yang XM AD - Department of Otolaryngology, Head and Neck Surgery, The Second Xiangya Hospital, Central South University, Changsha 410011, Hunan, PR China. Electronic address: x16y2003@aliyun.com. LA - eng PT - Journal Article DEP - 20170207 PL - Netherlands TA - Auris Nasus Larynx JT - Auris, nasus, larynx JID - 7708170 RN - EC 2.7.1.- (integrin-linked kinase) RN - EC 2.7.11.1 (Protein Serine-Threonine Kinases) SB - IM MH - Aged MH - Carcinoma, Squamous Cell/*metabolism/mortality/pathology MH - Female MH - Head and Neck Neoplasms/*metabolism/mortality/pathology MH - Humans MH - Kaplan-Meier Estimate MH - Laryngeal Neoplasms/*metabolism/mortality/pathology MH - Lymph Nodes/pathology MH - Lymphatic Metastasis MH - Male MH - Middle Aged MH - Multivariate Analysis MH - Neoplasm Grading MH - Neoplasm Staging MH - Prognosis MH - Protein Serine-Threonine Kinases/*metabolism MH - Squamous Cell Carcinoma of Head and Neck MH - Survival Analysis OTO - NOTNLM OT - Immunohistochemistry OT - Integrin-linked kinase OT - Laryngeal carcinoma OT - Metastases OT - Prognosis EDAT- 2017/02/12 06:00 MHDA- 2018/03/22 06:00 CRDT- 2017/02/12 06:00 PHST- 2015/11/02 00:00 [received] PHST- 2016/07/05 00:00 [revised] PHST- 2016/09/08 00:00 [accepted] PHST- 2017/02/12 06:00 [pubmed] PHST- 2018/03/22 06:00 [medline] PHST- 2017/02/12 06:00 [entrez] AID - S0385-8146(16)30364-9 [pii] AID - 10.1016/j.anl.2016.09.002 [doi] PST - ppublish SO - Auris Nasus Larynx. 2017 Aug;44(4):458-463. doi: 10.1016/j.anl.2016.09.002. Epub 2017 Feb 7.